📢✨ Good news from Clinical and Experimental Obstetrics & Gynecology (CEOG)! 📊 2025 JCR update: ✅ JIF increased from 0.6 to 0.9 ✅ Six consecutive years of JIF growth 📈🌱 🙏 Thanks to our Editor-in-Chief, Editorial Board, authors, reviewers & readers! 👉 Know more: imrpress.com/journal/CEOG #JCR2025 #ImpactFactor #WomensHealth #ObstetricsAndGynecology #ReproductiveHealth #ClinicalResearch #AcademicPublishing #ResearchImpact #ScholarlyPublishing #Women

📢 CEOG Special Issue, final weeks: Pregnancy Issues of the 21st Century A 12-week nuchal translucency scan and a decision to induce labor at term are filed under different headings, in different literatures. So why is one call for papers asking for both? #Obstetrics Because the two ends are reported in separate papers, and a reader of one rarely sees the other. A screening result appears without the delivery it pointed to; a delivery-room decision appears without the estimate behind it. What lets them be read as one is that the guest editors name a single instrument for the whole span: ultrasound, read with training and precision, plus the risk algorithms built on it. 🩺 First trimester: NT, NIPT, chromosomal risk 🤰 Later pregnancy: preeclampsia, gestational diabetes, growth restriction, cholestasis, twins 👶 At delivery: induction of labor, cesarean and operative delivery ✒️ Guest Editors: Luigi Carbone (MD, PhD), Raffaella Di Girolamo (MD) · Federico II University of Naples, Italy @UninaIT 📅 Closing 30 Nov 2026 · open access, double-blind review imrpress.com/journal/CEOG/sp… #MaternalHealth #WomensHealth #Preeclampsia #OBGYN #LoveUltrasound #ISUOG #Preeclampsia #CesareanRates #MaternalHealth

A tubo-ovarian abscess is a pocket of pus on an ovary and a tube. The biggest ones went to surgery, and those women went home first. So operating is the fast way out? #TuboOvarianAbscess 📊 They were the sickest women in the study: 85 mm mean abscess, against 72 mm with a drain and 52 mm on antibiotics alone. 🔬 Which makes the short stay look like a surgical win. It is not: hold arrival inflammation and antibiotic choice constant, and surgery stops explaining anything. The antibiotic combination is what is left, at about a third shorter. imrpress.com/journal/CEOG/53… #MedTwitter #OBGYN #MedEd #WomensHealth #surgery

👶 In Pennsylvania, 66 pregnant women have caught measles since April. So why is measles missing from a review of antiviral treatment in pregnancy? #Measles 📋 The review covers the viruses that can be drugged in pregnancy, from influenza to Ebola and Zika. 🧩 Measles is not one of them. There is no antiviral for it, and the only defense has to be finished before conception: MMR is a live vaccine, so it cannot be given once a woman is pregnant. 📊 For the viruses that can be treated, the difficulty shifts from the drug to the dose. Pregnancy lowers blood levels of some of them, and the review flags monitoring when the standard dose may not hold. Which drugs, which trimesters, and where the evidence still runs out: imrpress.com/journal/CEOG/49… #Measles #MeaslesOutbreak #MMR #MaternalHealth #Pregnancy #PublicHealth #VaccinesWork #Pennsylvania

😲 Ask Greek obstetricians how they would want their own baby delivered: four in five say vaginally. Then they go to work, where 62% of births are cesarean. Why? #CesareanSection ⚖️ Not because they don't know better. Litigation fear, older mothers, IVF, and thin training in operative vaginal delivery. 📊 And it isn't buying outcomes: perinatal mortality is at its highest in over a decade, above much of Western Europe. Greece lost a quarter of its births and gained obstetricians. Midwives are what it never had enough of. imrpress.com/journal/CEOG/53… #CesareanSection #CSection #OBGYN #MaternalHealth #Midwife

🦴 The pills that quiet chronic pelvic pain best are also the ones that thin bone. Fair trade? #ChronicPelvicPain 💊 Oral GnRH antagonists cut pain most consistently, but only inside endometriosis cohorts, one of three pain phenotypes. 📋 Those same trials logged vasomotor symptoms, menstrual changes, bone mineral density loss, and liver enzyme shifts. 🏃 Pain scores are also all those trials measured. Function and quality of life were measured elsewhere, and there the movement came from pelvic floor rehab and CBT/ACT, not from a pill. #WomensHealth 🧩 Same pain, different payoffs. Which therapy for which pain: the per-phenotype tables are here: 👉imrpress.com/journal/CEOG/53… #Endometriosis #ChronicPain #EndoWarrior

🧠 Polycystic ovary syndrome (PCOS) affects up to 1 in 10 women of reproductive age, yet no single test can diagnose it. So what settles it? 🩺 Three criteria: hyperandrogenism, oligo-anovulation, polycystic ovarian morphology. 🔬 But the underlying pathophysiology? Still largely unexplained. 📢 CEOG Special Issue on #PCOS: pathophysiology, diagnosis, clinical presentation, management. Insulin resistance at the center. 👥 Guest edited by Sungwook Chun, MD, PhD · Inje University College of Medicine, Haeundae Paik Hospital, Busan, Republic of Korea 📅 Submit by 31 Oct 2026 · double-blind review · open access imrpress.com/journal/CEOG/sp… #WomensHealth #PMOS

🔍 We asked a surgeon who trains other surgeons: will AI replace you? Prof. Jose Antonio Carugno @TonyCarugno , CEOG Editorial Board member, expects AI to become "a powerful assistive tool rather than a replacement for the surgeon." 🤖 And his reason is the part most people miss. It is not the algorithms: gynecologic surgery lacks the large, diverse, well-annotated datasets to train them. An algorithm that shines in one hospital can fail on a rare complication in another. 📊 On new devices, he is just as blunt: they often reach the OR before the data that should judge them. His yardstick: "Progress should be measured by outcomes that matter to patients, not by the novelty of the technology." 💬 Your turn: what evidence would you demand before a new device reaches your operating room? Full interview: imrpress.com/journal/CEOG/pa… #AIinHealthcare #AIinSurgery #MedTwitter

🌸 In lab models of hypertensive pregnancy, a centuries-old #Kampo herb showed the potential to improve placental blood flow — by raising placental growth factor, easing an angiogenic imbalance, and limiting oxidative damage. Could that help women once they were already in hospital? 📋 A national Japanese inpatient database included 11,264 women hospitalized with hypertensive disorders of pregnancy and already on oral antihypertensives. Only 85 also received Tokishakuyakusan in the first three days. 📊 Against antihypertensives alone, there was no significant difference in disease progression, maternal adverse events, or preterm birth. A clear benefit was not shown. Nor was a major new safety concern. 🧩 The authors do not treat that as proof the herb fails. With 85 patients, a real effect could still have been missed. A prospective study large enough to settle it has not been done. Every number is in the paper 👇 imrpress.com/journal/CEOG/53… #Tokishakuyakusan #HDP #Preeclampsia #MaternalHealth #ObGyn #RealWorldEvidence

👶 Can cesarean history help a #PlacentaAccretaSpectrum team anticipate surgical complexity before the first incision? 🔬 A Saudi clinical audit followed 36 PAS cases managed through a standardized multidisciplinary pathway. 📊 With three or more prior cesareans, blood loss, bladder injury, operating time, and ICU stay all showed a numerical rise. 🧩 How did that signal shape anesthesia, transfusion readiness, and surgical support? The pathway and outcome comparisons are in the paper 👇 imrpress.com/journal/CEOG/53… #PAS #PlacentaAccreta #OBGYN #MFM #OBAnes #Cesarean #PPH #MedTwitter #MaternalHealth

🤰 A dinoprostone insert ripens the cervix for induction. With membranes already ruptured, induction should get easier — not harder. 📊 Reality: after the same insert, PROM pregnancies showed less cervical dilatation and less effacement than intact-membrane controls. 🔄 Yet instead of an easier delivery, the cesarean rate rose — driven by fetal distress, 35.7% vs 16.7% (p=0.008). 📋 Cohort: 42 PROM vs 84 controls, singletons ≥37 weeks, single centre, 2020–2025 — and the PROM group started with more pre-induction dilatation. 🔍 So what does early membrane rupture do to cervical ripening — and does the gap survive adjustment for gestational age? The whole adjusted story is in the paper 👇 imrpress.com/journal/CEOG/53… #MedTwitter #ObGyn #FOAMed #LaborInduction #PROM #CervicalRipening #Cesarean #MedEd

🩺 If V-NOTES wins on blood loss, hospital stay, ambulation and pain, is the technique really the reason? In 87 women aged 60+ having minimally invasive hysterectomy, it beat TLH on nearly every recovery measure. Adjust for age and BMI, and only one gap survives: day-1 pain (β = −1.16). 🚪 The 5 of 49 planned V-NOTES that converted to laparotomy were graded Clavien-Dindo IIIb, and sit outside the comparison. ⚡ Every abdominal-wound complication sat in the TLH arm. Which recovery gains belong to the approach, and which to who was selected for it 👇 imrpress.com/journal/CEOG/53… #vNOTES #hysterectomy #MIGS #WomensHealth #Gynecology #ObGyn #EBM #PatientSelection

🤰 The HALP score was built to measure immune and nutritional reserve. So why does it read highest in the sickest pregnancies? 🩸 Not because anything improved. Platelets, the denominator, fell by about a third, and that single drop carried the score upward across 312 pregnancies. 📉 Does the change beat the platelet count on its own? How far do preterm birth and HELLP climb above the cutoff? Both answers, with every number, are in the paper 👇 🔗 imrpress.com/journal/CEOG/53… #OBGYN #Obstetrics #MaternalHealth #HELLP #PretermBirth #MedTwitter #WomensHealth

Still treating every hot flash with the same prescription? #Menopause A new evidence-based review says the fixed protocol is the problem, not the symptoms. 1· 🧠 Why: estrogen loss overactivates KNDy neurons, excess neurokinin B hits NK3 receptors and narrows the thermoneutral zone 2· 💊 MHT works best inside the timing window (under 60 or within 10 years of onset), lowest dose, transdermal to cut stroke and VTE risk 3· 🌿 No MHT? SSRIs/SNRIs cut flashes 40–65%, gabapentinoids 45–60%, fezolinetant works in 4 weeks and holds to 52 4· 🥗 Lifestyle is not a footnote: low-fat vegan diet plus daily soy cut moderate-severe flashes 88% in 12 weeks; hypnosis up to 50% #Menopause #Perimenopause #HotFlashes #VMS #HRT #MHT #Veozah #WomensHealth #HormoneHealth #MidlifeWomen

🤰Does it matter WHICH OGTT value is abnormal in pregnancy? Risk is a gradient, not a binary #GDM label. 1⃣LGA prevalence was 6.3% in normoglycemic women vs 26.6% in those with ≥2 abnormal values (aOR 10.5; n=1,457). 2⃣But fasting-dominant hyperglycemia carried the highest risk (aOR 8.1; insulin therapy 37.5% vs 0%). 3⃣Isolated 1-h/2-h abnormalities were milder (aOR ≈4.9). #GDM #GestationalDiabetes #OGTT #Pregnancy #Pregnant #Diabetes #BloodSugar #GestationalDiabetesDiet #HealthyPregnancy #PrenatalCare #MomToBe #PregnancyJourney #DiabetesAwareness #HighRiskPregnancy #OBGYN

After #LACC, does MIS still have a place in early-stage #CervicalCancer? 📉 Final LACC analysis: MIS 4.5-yr DFS 85% vs open 96% (HR 3.91) — open surgery remains the standard. 📊 But in low-risk ≤2 cm disease, MIS matched open: 5-yr OS 98.6% vs 99.3% (p=0.571). 🎯 Authors' take: not routine. Reserve MIS for selected patients, high-volume centers, with tumor containment — ideally in trials. #CervicalCancerAwareness #MIGS #Hysterectomy #GynOnc #LACC #RoboticSurgery #Oncology #WomensHealth

🩺 Can tumor size alone predict whether a postmenopausal giant ovarian mass (≥20 cm / ≥10 kg) is malignant? #GiantOvarianTumor A systematic review of 22 open-laparotomy cases (2010–2025) says no: extreme dimensions didn't predict cancer. 📊 Malignancy was the minority: 68.2% benign, 9.1% borderline, 22.7% malignant, across masses 20–58 cm. 🔬 Spillage happened in 36.4% of surgeries, so preserving capsular integrity, especially for mucinous tumors, is a key operative goal. 📋 All 22 cases used midline laparotomy; TAH-BSO was done in 40.9%, and perioperative complications hit 45.5% (1 death). ⚠️ Evidence is case-report only, so minimally invasive feasibility and prognosis stay open questions. 🔭 Takeaway: size alone shouldn't drive the malignancy call; careful staging and intact-envelope surgery matter most. #OvarianCancer #GynOnc #OBGYN #WomensHealth #Menopause #Oncology #GynecologicOncology #SurgicalOncology #SystematicReview

🧐Can a combined biometry + Doppler model spot high-risk late-onset FGR fetuses? #FetalGrowthRestriction 📋 Retrospective study, 91 late-onset FGR cases; adverse outcomes in 71.4%. 📡 Ductus venosus Doppler (DV-PIV >95th pct) was the only Doppler parameter tied to adverse outcomes (OR 3.83). 🧩 Combined model (maternal age + biometry + DV-PIV) outperformed single markers: AUC 0.747, PPV 88.4%. ⚠️ But sensitivity 58.5% and NPV 43.8% limit it; external validation needed before clinical use. #MFM #OBGYN #PrenatalCare #Ultrasound #HighRiskPregnancy #FetalMedicine #NIPT #FetalUltrasound

🧠 Can a drop of platelet-rich plasma double IVM success? #IVM Prospective cohort, 28 GV oocytes from 15 PMOS women. 1⃣ Conclusion: 5% allogeneic PRP significantly boosted IVM maturation (21.4% → 71.4%, p = 0.021) and ICSI fertilization (80% vs 0%). 2⃣ Dose matters: 25-50% PRP caused clumping, so 5% is the optimal concentration. 3⃣ Pilot evidence only; larger confirmatory trials are needed before clinical use. #IVM #OocyteMaturation #PlateletRichPlasma #FertilityResearch #AssistedReproduction #ReproductiveHealth #InVitroMaturation

🧠 Can a virtual window halve pain during office hysteroscopy? #Hysteroscopy Randomized pilot, 50 women (25/25), N2O ± multisensory visual distraction. 1⃣Pain (NRS 0-10): 5.8 ± 1.9 → 3.1 ± 1.5 with visual distraction (p < 0.001). 2⃣Reduction held across techniques; no adverse events; OR referral unchanged (20% vs 12%, p = 0.702). 3⃣Pilot only: n=50, unblinded, single subjective measure. Multicenter trials needed.